DK0553113T3 - Adhæsionsreceptorer for patogene eller opportunistiske mikroorganismer - Google Patents
Adhæsionsreceptorer for patogene eller opportunistiske mikroorganismerInfo
- Publication number
- DK0553113T3 DK0553113T3 DK91916508T DK91916508T DK0553113T3 DK 0553113 T3 DK0553113 T3 DK 0553113T3 DK 91916508 T DK91916508 T DK 91916508T DK 91916508 T DK91916508 T DK 91916508T DK 0553113 T3 DK0553113 T3 DK 0553113T3
- Authority
- DK
- Denmark
- Prior art keywords
- 3galb1
- galb1
- methods
- receptors
- pathogenic
- Prior art date
Links
- 244000005700 microbiome Species 0.000 title abstract 3
- 230000001717 pathogenic effect Effects 0.000 title abstract 3
- 102000019997 adhesion receptor Human genes 0.000 title 1
- 108010013985 adhesion receptor Proteins 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 150000003410 sphingosines Chemical group 0.000 abstract 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 abstract 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 abstract 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 229940106189 ceramide Drugs 0.000 abstract 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 abstract 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical group CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56200290A | 1990-08-02 | 1990-08-02 | |
| PCT/US1991/005179 WO1992002817A1 (en) | 1990-08-02 | 1991-07-29 | Adhesion receptors for pathogenic or opportunistic microorganisms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0553113T3 true DK0553113T3 (da) | 1999-08-09 |
Family
ID=24244391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91916508T DK0553113T3 (da) | 1990-08-02 | 1991-07-29 | Adhæsionsreceptorer for patogene eller opportunistiske mikroorganismer |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5696000A (de) |
| EP (1) | EP0553113B1 (de) |
| JP (1) | JPH06501383A (de) |
| AT (1) | ATE173827T1 (de) |
| CA (1) | CA2095642C (de) |
| DE (1) | DE69130536T2 (de) |
| DK (1) | DK0553113T3 (de) |
| ES (1) | ES2127198T3 (de) |
| WO (1) | WO1992002817A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736533A (en) * | 1995-06-07 | 1998-04-07 | Neose Technologies, Inc. | Bacterial inhibition with an oligosaccharide compound |
| WO1997018790A2 (en) * | 1995-11-22 | 1997-05-29 | The Research And Development Institute, Inc. | Therapeutic and diagnostic agents for the treatment of microbial infections |
| US5939404A (en) * | 1995-12-27 | 1999-08-17 | Ngk Insulators, Ltd. | Cancer metastasis inhibitor containing a streptococcus agalactiae Ia type or Ib type surface polysaccharide as a main ingredient |
| US6207157B1 (en) * | 1996-04-23 | 2001-03-27 | The United States Of America As Represented By The Department Of Health And Human Services | Conjugate vaccine for nontypeable Haemophilus influenzae |
| WO1998037915A1 (en) * | 1997-02-26 | 1998-09-03 | Hsc Research And Development Limited Partnership | Antibiotic-ligand conjugates and methods of use thereof |
| WO1999043356A1 (en) * | 1998-02-25 | 1999-09-02 | Hsc Research Development Limited Partnership | Antibiotic-ligand conjugates and methods of use thereof |
| AUPQ275799A0 (en) | 1999-09-10 | 1999-10-07 | Luminis Pty Limited | Recombinant bacterium expressing an oligosaccharide receptor mimic |
| GB0001450D0 (en) * | 2000-01-21 | 2000-03-08 | Genpoint As | Cell isolation method |
| US6869602B2 (en) * | 2002-02-20 | 2005-03-22 | The United States Of America As Represented By The Secretary Of The Army | Method for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections with bovine red blood cells |
| US20030176326A1 (en) * | 2002-03-15 | 2003-09-18 | Ceramoptec Industries Inc. | Photosensitzers for photodynamic therapy of microbial infections |
| PT1629850E (pt) | 2004-08-24 | 2007-08-14 | Nutricia Nv | Composição nutricional que compreende a administração de oligossacarídeos indigeríveis |
| GB0502095D0 (en) | 2005-02-01 | 2005-03-09 | Chiron Srl | Conjugation of streptococcal capsular saccharides |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4034074A (en) * | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US4134792A (en) * | 1976-12-06 | 1979-01-16 | Miles Laboratories, Inc. | Specific binding assay with an enzyme modulator as a labeling substance |
| US4271140A (en) * | 1978-01-23 | 1981-06-02 | Baxter Travenol Laboratories, Inc. | Method and composition for double receptor, specific binding assays |
| US4299916A (en) * | 1979-12-26 | 1981-11-10 | Syva Company | Preferential signal production on a surface in immunoassays |
| SE8001748L (sv) * | 1980-03-05 | 1981-09-06 | Kaellenius Gunilla | Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik |
| EP0058665B1 (de) * | 1980-05-09 | 1986-02-26 | LEFFLER, Hakon | Carbohydrat-derivate zum hemmen eines bakteriellen anhaftens |
| US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4474892A (en) * | 1983-02-16 | 1984-10-02 | Board Of Trustees Of The Leland Stanford Junior University | Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same |
| SE8301609D0 (sv) * | 1983-03-23 | 1983-03-23 | Svenska Sockerfabriks Ab | Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling |
| US4762713A (en) * | 1983-07-05 | 1988-08-09 | The University Of Rochester | Boosting of immunogenic conjugate vaccinations by unconjugated bacterial capsular polymers |
| DK219084D0 (da) * | 1984-05-02 | 1984-05-02 | Frederik Carl Peter Lindberg | Antigen |
| US4610868A (en) * | 1984-03-20 | 1986-09-09 | The Liposome Company, Inc. | Lipid matrix carriers for use in drug delivery systems |
| US4762800A (en) * | 1984-04-26 | 1988-08-09 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies to cell surface antigens of human teratocarcinomas |
| DK17885D0 (da) * | 1985-01-14 | 1985-01-14 | Karlsson Karl Anders | Antiviralt middel |
| US4661345A (en) * | 1985-02-26 | 1987-04-28 | The Rockefeller University | Method for treating pertussis |
| US4786592A (en) * | 1986-06-18 | 1988-11-22 | Scripps Clinic And Research Foundation | Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin |
| IT1235011B (it) * | 1988-07-26 | 1992-06-16 | Fidia Farmaceutici | Sintesi di derivati di glicosfingolipidi ed in particolare di gangliosidi utilizzabili per la preparazione di immunoadsorbenti ed adsorbenti per affinita' impiegabili per la purificazione di anticorpi e di tossine specifiche, e per uso diagnostico |
| US5217715A (en) * | 1988-08-01 | 1993-06-08 | The United States Of America As Represented By The Department Of Health And Human Services | Carbohydrate receptor for bacteria and method for use thereof |
| US5225330A (en) * | 1988-08-01 | 1993-07-06 | The United States Of America As Represented By The Department Of Health And Human Services | Diagnostic kit and diagnostic method utilizing carbohydrate receptors |
| US4969540A (en) * | 1989-09-28 | 1990-11-13 | Allied-Signal Inc. | Center loop anti-rattle spring |
-
1991
- 1991-07-29 CA CA002095642A patent/CA2095642C/en not_active Expired - Fee Related
- 1991-07-29 EP EP91916508A patent/EP0553113B1/de not_active Expired - Lifetime
- 1991-07-29 ES ES91916508T patent/ES2127198T3/es not_active Expired - Lifetime
- 1991-07-29 JP JP3515061A patent/JPH06501383A/ja active Pending
- 1991-07-29 WO PCT/US1991/005179 patent/WO1992002817A1/en active IP Right Grant
- 1991-07-29 DE DE69130536T patent/DE69130536T2/de not_active Expired - Fee Related
- 1991-07-29 AT AT91916508T patent/ATE173827T1/de not_active IP Right Cessation
- 1991-07-29 DK DK91916508T patent/DK0553113T3/da active
-
1994
- 1994-07-18 US US08/275,702 patent/US5696000A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2127198T3 (es) | 1999-04-16 |
| ATE173827T1 (de) | 1998-12-15 |
| DE69130536D1 (de) | 1999-01-07 |
| EP0553113A1 (de) | 1993-08-04 |
| WO1992002817A1 (en) | 1992-02-20 |
| DE69130536T2 (de) | 1999-04-22 |
| EP0553113B1 (de) | 1998-11-25 |
| US5696000A (en) | 1997-12-09 |
| JPH06501383A (ja) | 1994-02-17 |
| EP0553113A4 (de) | 1994-03-30 |
| CA2095642C (en) | 1999-12-14 |
| CA2095642A1 (en) | 1992-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5256641A (en) | Covalent polar lipid-peptide conjugates for immunological targeting | |
| DK0553113T3 (da) | Adhæsionsreceptorer for patogene eller opportunistiske mikroorganismer | |
| LV12766A (lv) | Composition of l-dopa esters | |
| FR2442054A1 (fr) | Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant | |
| ATE178907T1 (de) | Rezeptorbindende region des diphtherietoxius | |
| US5756449A (en) | Peptide T and related peptides in the treatment of inflammation, including inflammatory bowel disease | |
| DK0769020T3 (da) | Nye hIL-4-mutantproteiner som antagonister eller delvise agonister for det humane interleukin-4 | |
| BRPI0411505A (pt) | uso de um composto, método para modular a resposta imune de um indivìduo, composição farmacêutica, vacina, complexo, e, kit para a captura de uma molécula biologicamente ativa | |
| NZ332311A (en) | Use of autoantigen HC gp-39 and proteins structurally related thereto in immunotherapy of autoimmune diseases particularly rheumatoid arthritis | |
| FR2762993B1 (fr) | Nouvelle utilisation de phospholipides d'origine animale en therapeutique et/ou dietetique | |
| Torres et al. | Arginine vasopressin (AVP) replacement of helper cell requirement in IFN-gamma production. Evidence for a novel AVP receptor on mouse lymphocytes. | |
| ATE258933T1 (de) | Übergangszustand-analoga des kokains, ihre verwendung zur herstellung von kataltischen antikörpern gegen kokain und verwendung derselben in diagnose und therapie | |
| MX9302327A (es) | Aminoacidos ciclicos novedosos y derivados de los mismos. | |
| ATE237343T1 (de) | Retropeptide, antikörper dagegen und deren verwendungen in der impfung und in vitro diagnostik | |
| US6011014A (en) | Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis | |
| DE69816808D1 (de) | Somatostatin agoniste zur reduzierung von körpergewicht | |
| TNSN92115A1 (fr) | Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation | |
| Krueger | Somnogenic activity of muramyl peptides | |
| Rees et al. | The effect of lipoylation on CD4 T-cell recognition of the 19,000 MW Mycobacterium tuberculosis antigen. | |
| DE69923996D1 (de) | Methode für die herstellung von gereinigtem invasinprotein und seine anwendung | |
| AU2254999A (en) | Use of peptide T in the treatment of multiple sclerosis | |
| DE50011068D1 (de) | Fragmente des virus proteins 2 oder 3 des polyomavirus als fähren für wirkstoffe | |
| FR2694938B1 (fr) | Nouveaux peptides, anticorps diriges contre ces peptides, anticorps anti-idiotypiques, application a titre de medicaments, compositions pharmaceutiques et kits de diagnostic les renfermant. | |
| RU2130317C1 (ru) | Линейные или циклические пептиды, их применение, способ лечения | |
| Brown et al. | Extension of a minimal T cell determinant allows relaxation of the requirement for particular residues within the determinant |